Las Vegas, NV -- (SBWIRE) -- 01/28/2014 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks: Affymax, Inc.(OTCMKTS:AFFY), Vapor Corp.,(OTCMKTS:VPCOD), International Stem Cell Corp(OTCMKTS:ISCO), La Jolla Pharmaceutical Company(OTCBB:LJPCD).
Affymax, Inc.(OTCMKTS:AFFY) ended lower -5.43% and complete the day at $0.871. The total number of shares changed hands during the day was 524,743. After opening at $0.92, the stock hit as high as $0.93. However, it traded between $0.74 and $19.72 over the last twelve months. Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions.
Has AFFY Found The Bottom and Ready To Move Up? Find Out Here
Vapor Corp.,(OTCMKTS:VPCOD) closed yesterday at $8.45, a -4.52% decrease. Around 70,886 shares were traded, lower from an-average trading volume of 96,365 shares. The company is now valued at around $137.00 million. Vapor Corp (Vapor) is engaged in designing, marketing and distributing electronic cigarettes and accessories under the Fifty-One, Krave, VaporX, EZ Smoker, Green Puffer.
Has VPCOD Found The Bottom And Ready To Gain Momentum? Find Out Here
International Stem Cell Corp(OTCMKTS:ISCO) moved -1.79 percent lower at $0.220 and traded between $0.22 and $0.24 after opening the day at $0.23. Its performance over the last five days remained 2.33%, which stands at -0.09% for a month. Going back further than one month, 1-year performance after recent close was 2.42%.International Stem Cell Corporation is a developmental-stage biotechnology company. The Company focused on therapeutic, biomedical and cosmeceutical product.
Why Should Investors Buy ISCO After the Recent Fall? Just Go Here and Find Out
La Jolla Pharmaceutical Company(OTCBB:LJPCD) shares fall, losing -6.43 percent to close at $7.86. The stock is up around 8173.68% this year and 8633.33% for the last 12 months. Around 47,609 shares changed hands yesterday, lower from an-average trading volume of 70,153 shares. La Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the development of treatments that inhibits the activity of galectins as a means of treating human diseases, such as cancer and chronic organ failure.
Will LJPCD Get Buyers Even After The Recent Rally? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)